Products

Primary tabs

Export products to Excel

Displaying 121 - 135 of 205
Alternative Name: Nestorone (NES) Metered Dose Transdermal System® (MDTS®)
Development Status: Inactive
Target: Female
Mode: Hormonal
Delivery Type: Transdermal
Project Stage: Phase I
Target: Female
Mode: Hormonal
Delivery Type: Subdermal
Project Stage: Pre-clinical
Alternative Name: Nestorone (NES) + Estradiol (E2) Transdermal Gel
Development Status: Active Development
Target: Female
Mode: Hormonal
Delivery Type: Transdermal
Project Stage: Phase II
Alternative Name: Biodegradable Norethindrone (NET) Pellets
Development Status: Inactive
Target: Female
Mode: Hormonal
Delivery Type: Subdermal
Project Stage: Phase II
Alternative Name: Lavax Vaginal Suppository
Development Status: Active Development
Target: Female
Mode: Non-hormonal
Delivery Type: Vaginal, Other
Project Stage: Target ID/Validation
Partner: Lavax
Development Status: Active Development
Target: Male
Mode: Non-hormonal
Delivery Type: Oral
Alternative Name: Nomegestrol acetate (NOMAC) vaginal ring
Development Status: Active Development
Target: Female
Mode: Hormonal
Delivery Type: Vaginal Ring
Partner: Merck
Alternative Name: Non-Invasive Laser Male Sterilization
Development Status: Inactive
Target: Male
Mode: Non-hormonal
Delivery Type: Vas Deferens
Project Stage: Pre-clinical
Development Status: Active Development
Target: Female
Mode: Hormonal
Delivery Type: Transdermal
Project Stage: Regulatory
Partner: Actavis
Alternative Name: Oil-based drospirenone (DSRP) microcrystal suspension
Development Status: Inactive
Target: Female
Mode: Hormonal
Delivery Type: Injectable
Project Stage: Pre-clinical
Partner: Bayer HealthCare
Development Status: Inactive
Target: Male
Mode: Non-hormonal
Delivery Type: Oral
Project Stage: Pre-clinical
Development Status: Active Development
Target: Female
Mode: Non-hormonal
Delivery Type: Intrauterine
Development Status: Active Development
Target: Female
Mode: Hormonal
Delivery Type: Intrauterine
Project Stage: Regulatory
Alternative Name: ZK 98.299, ZK 98 299
Development Status: Inactive
Target: Female
Mode: Hormonal
Delivery Type: TBD
Project Stage: Pre-clinical
Partner: Schering AG
Target: Male
Mode: Hormonal
Delivery Type: Oral
Project Stage: Phase I
Export to Excel